Australia markets closed

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
254.77-0.08 (-0.03%)
At close: 04:00PM EST
254.77 0.00 (0.00%)
After hours: 05:36PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 72.05B
Enterprise value 110.52B
Trailing P/E 14.40
Forward P/E 14.04
PEG ratio (5-yr expected) 1.43
Price/sales (ttm)1.29
Price/book (mrq)N/A
Enterprise value/revenue 1.85
Enterprise value/EBITDA 8.84

Trading information

Stock price history

Beta (5Y monthly) 1.65
52-week change 36.13%
S&P500 52-week change 3-9.85%
52-week high 3279.02
52-week low 3164.47
50-day moving average 3243.59
200-day moving average 3214.97

Share statistics

Avg vol (3-month) 31.26M
Avg vol (10-day) 31.72M
Shares outstanding 5282.72M
Implied shares outstanding 6N/A
Float 8212M
% held by insiders 125.47%
% held by institutions 166.75%
Shares short (12 Jan 2023) 42.92M
Short ratio (12 Jan 2023) 42.78
Short % of float (12 Jan 2023) 41.38%
Short % of shares outstanding (12 Jan 2023) 41.03%
Shares short (prior month 14 Dec 2022) 43.68M

Dividends & splits

Forward annual dividend rate 42.4
Forward annual dividend yield 40.94%
Trailing annual dividend rate 32.24
Trailing annual dividend yield 30.88%
5-year average dividend yield 4N/A
Payout ratio 412.20%
Dividend date 327 Dec 2022
Ex-dividend date 415 Mar 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 9.37%
Operating margin (ttm)15.03%

Management effectiveness

Return on assets (ttm)10.97%
Return on equity (ttm)965.25%

Income statement

Revenue (ttm)60.23B
Revenue per share (ttm)204.41
Quarterly revenue growth (yoy)2.90%
Gross profit (ttm)23.18B
Net income avi to common (ttm)5.64B
Diluted EPS (ttm)19.15
Quarterly earnings growth (yoy)14.70%

Balance sheet

Total cash (mrq)908M
Total cash per share (mrq)3.18
Total debt (mrq)39.84B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.38
Book value per share (mrq)-9.69

Cash flow statement

Operating cash flow (ttm)8.52B
Levered free cash flow (ttm)3.35B